Overview

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
0
Participant gender:
All
Summary
The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Fluoroquinolones
Gatifloxacin
Ophthalmic Solutions
Tetrahydrozoline
Criteria
Inclusion Criteria:

- Clinically diagnosed with bacterial conjunctivitis

Exclusion Criteria:

- Signs and/or symptoms of conjunctivitis for more than 96 hours

- Signs and/or symptoms suggestive of fungal, viral, or allergic conjunctivitis

- Clinical diagnosis of chlamydia in either eye